776 ITIL-306–201: A multicenter, first-in-human phase 1a/1b study of ITIL-306, an engineered autologous tumor-infiltrating lymphocyte (TIL) cell therapy product, in adults with advanced solid tumor

التفاصيل البيبلوغرافية
العنوان: 776 ITIL-306–201: A multicenter, first-in-human phase 1a/1b study of ITIL-306, an engineered autologous tumor-infiltrating lymphocyte (TIL) cell therapy product, in adults with advanced solid tumor
المؤلفون: Ward, Jeffrey, Ghobadi, Armin, Liao, John, Schoenfeld, Adam, Tykodi, Scott, Jiang, Yizhou, Gall, John Le, Alvarez-Rodriguez, Ruben, Sherman, Marika, Singson, Tiffany, McLeroy, Jeffrey
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2022
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2022-sitc2022.0776
DOI: 10.1136/jitc-2022-SITC2022.0776
الإتاحة: https://doi.org/10.1136/jitc-2022-sitc2022.0776Test
رقم الانضمام: edsbas.CE95A7F3
قاعدة البيانات: BASE